Axsome Therapeutics, Inc.·4

Mar 6, 6:14 PM ET

Pizzie Nick 4

4 · Axsome Therapeutics, Inc. · Filed Mar 6, 2023

Insider Transaction Report

Form 4
Period: 2023-03-02
Pizzie Nick
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-02+36,24636,246 total
    Exercise: $65.32Exp: 2033-03-01Common Stock (36,246 underlying)
  • Award

    Restricted Stock Units

    2023-03-02+20,55420,554 total
    Common Stock (20,554 underlying)
Footnotes (3)
  • [F1]The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 2, 2027.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 2, 2027. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION